| Document Date: 2011-07-08 12:49:28
Open Document File Size: 1.002,42 KBShare Result on Facebook
Company GlaxoSmithKline / Synta Pharmaceuticals / SPEDOC PARTNERS / / Currency USD / EUR / / / Event FDA Phase / Business Partnership / / Facility The Institute / / IndustryTerm treatment follow-up devices / biotechnology / optical devices / portable device / tabletop turnkey device / cancer therapy / treatment of cancer / recent years new technologies / nanofabrication plasmonic devices / cancer treatment / e-beam / care device / surface chemistry protocol / imaging / integrated optical device / / MedicalCondition cancers / tumor / future individualized cancer / cancer / disease / tumour / illness / tumours / at detecting the disease / / MedicalTreatment cancer therapy / / Organization Ecole Polytechnique Federale de Lausanne / Congress / Institute of Photonic Sciences / European Commission / American Cancer Society / / Person Olivier Martin / Sebastian Maerkl / Rafael Porcar / Raman Scattering / Alain Dereux / Carmen Garrigo / Romain Quidant / / Position Scientific Coordinator / Principal Investigator / coordinator / Mireia Casanovas Project Manager / / / Product HSP70 / / Technology cancer detection / optical sensing / antibodies / biotechnology / treating cancer / spectroscopy / lithography / surface chemistry protocol / microfluidics / fabricated using e-beam lithography / / URL www.spedoc.eu / http /
SocialTag |
MARCHSPEDOC NEWSLETTER 2011 www.spedoc.eu